<bill session="116" type="h" number="321" updated="2019-07-30T13:08:01Z">
  <state datetime="2019-01-08">REFERRED</state>
  <status>
    <introduced datetime="2019-01-08"/>
  </status>
  <introduced datetime="2019-01-08"/>
  <titles>
    <title type="official" as="introduced">To amend the Public Health Service Act to create a National Neuromyelitis Optica Consortium to provide grants and coordinate research with respect to the causes of, and risk factors associated with, neuromyelitis optica, and for other purposes.</title>
    <title type="short" as="introduced">Neuromyelitis Optica Consortium Act</title>
    <title type="short" as="introduced">Neuromyelitis Optica Consortium Act</title>
    <title type="display">Neuromyelitis Optica Consortium Act</title>
  </titles>
  <sponsor bioguide_id="L000551"/>
  <cosponsors/>
  <actions>
    <action datetime="2019-01-08">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-01-08" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2019-01-25">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Department of Health and Human Services"/>
    <term name="Executive agency funding and structure"/>
    <term name="Health programs administration and funding"/>
    <term name="Hearing, speech, and vision care"/>
    <term name="Medical research"/>
    <term name="National Institutes of Health (NIH)"/>
    <term name="Neurological disorders"/>
    <term name="Research administration and funding"/>
  </subjects>
  <amendments/>
  <summary date="2019-01-08T05:00:00Z" status="Introduced in House">Neuromyelitis Optica Consortium Act

This bill requires the National Institutes of Health to establish, administer, and coordinate a national consortium on neuromyelitis optica (NMO), which is a neurological disease that can cause blindness and paralysis.

The consortium must

 award grants for research on the causes of, and the risk factors and biomarkers associated with, NMO; assemble a panel of experts to provide guidance and recommendations on research design and protocols; and designate a central laboratory to collect and analyze data from this research and to make the data and analysis available to researchers.</summary>
  <committee-reports/>
</bill>
